Jingpin Jia

Title: **The Innovative Contributions of Inventor Jingpin Jia**

Introduction

Jingpin Jia, an accomplished inventor based in Belle Mead, NJ, has made significant strides in the field of pharmaceutical innovations. With a strong background in biochemistry and pharmaceutical sciences, Jia has successfully contributed to the development of important medical formulations crucial for treating thromboembolic disorders.

Latest Patents

Jia holds a notable patent for "Apixaban formulations," which involves compositions comprising crystalline apixaban particles with a diameter equal to or less than 89 micrometers, combined with a pharmaceutically acceptable carrier. This formulation is particularly significant as it is substantially bioequivalent and aims to assist in the treatment and/or prophylaxis of thromboembolic disorders.

Career Highlights

Throughout his career, Jingpin Jia has been associated with renowned companies such as Bristol-Myers Squibb Company and Pfizer Corporation. His work at these leading pharmaceutical firms has allowed him to harness his expertise, fostering the development of innovative drug formulations and improving patient health outcomes.

Collaborations

Jingpin Jia has collaborated with talented professionals in the industry, including notable colleagues such as Jatin M. Patel and Charles Frost. These collaborations have contributed to the advancement of pharmaceutical research, enhancing the effectiveness of treatments available to patients.

Conclusion

Jingpin Jia's contributions to pharmaceutical innovations, particularly through his patent on apixaban formulations, exemplify his dedication to improving medical treatments for thromboembolic disorders. His collaborations with esteemed colleagues and work at leading pharmaceutical companies highlight his commitment to advancing healthcare solutions, making him a vital figure in the field of pharmacy and innovation.